BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36656832)

  • 1. Qualitative hepatitis C virus RNA assay identifies active infection with sufficient viral load for treatment among Phetchabun residents in Thailand.
    Pratedrat P; Nilyanimit P; Wasitthankasem R; Posuwan N; Auphimai C; Hansoongnern P; Pimsing N; Ngamnimit S; Thongmai C; Phaengkha W; Wanlapakorn N; Vongpunsawad S; Poovorawan Y
    PLoS One; 2023; 18(1):e0268728. PubMed ID: 36656832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Hepatitis C Virus in an Endemic Area of Thailand: Burden Assessment toward HCV Elimination.
    Wasitthankasem R; Pimsingh N; Treesun K; Posuwan N; Vichaiwattana P; Auphimai C; Thongpan I; Tongsima S; Vongpunsawad S; Poovorawan Y
    Am J Trop Med Hyg; 2020 Jul; 103(1):175-182. PubMed ID: 32394881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simplified Test-to-Treat Strategy for Hepatitis C in Thailand: The Phetchabun Model.
    Wasitthankasem R; Wanlapakorn N; Pimsing N; Posuwan N; Poovorawan Y
    J Infect Dis; 2023 Sep; 228(Suppl 3):S198-S203. PubMed ID: 37703343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of hepatitis C virus infection in two adjacent Thai provinces with drastically different seroprevalence.
    Wasitthankasem R; Vichaiwattana P; Siripon N; Posuwan N; Auphimai C; Klinfueng S; Thaneskongtong N; Vuthitanachot V; Saiyatha S; Thongmai C; Suwanpatoomlerd S; Sochoo S; Pongsuwan N; Poovorawan K; Tangkijvanich P; Vongpunsawad S; Poovorawan Y
    PLoS One; 2017; 12(5):e0177022. PubMed ID: 28475637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreasing Hepatitis C Virus Infection in Thailand in the Past Decade: Evidence from the 2014 National Survey.
    Wasitthankasem R; Posuwan N; Vichaiwattana P; Theamboonlers A; Klinfueng S; Vuthitanachot V; Thanetkongtong N; Saelao S; Foonoi M; Fakthongyoo A; Makaroon J; Srisingh K; Asawarachun D; Owatanapanich S; Wutthiratkowit N; Tohtubtiang K; Yoocharoen P; Vongpunsawad S; Poovorawan Y
    PLoS One; 2016; 11(2):e0149362. PubMed ID: 26871561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter Evaluation of the Cepheid Xpert Hepatitis C Virus Viral Load Assay.
    McHugh MP; Wu AHB; Chevaliez S; Pawlotsky JM; Hallin M; Templeton KE
    J Clin Microbiol; 2017 May; 55(5):1550-1556. PubMed ID: 28275079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Birth-cohort HCV screening target in Thailand to expand and optimize the national HCV screening for public health policy.
    Wasitthankasem R; Vichaiwattana P; Siripon N; Posuwan N; Auphimai C; Klinfueng S; Thanetkongtong N; Vuthitanachot V; Saiyatha S; Thongmai C; Sochoo S; Sukthong P; Poovorawan K; Tangkijvanich P; Poovorawan Y
    PLoS One; 2018; 13(8):e0202991. PubMed ID: 30138441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus.
    Llibre A; Shimakawa Y; Mottez E; Ainsworth S; Buivan TP; Firth R; Harrison E; Rosenberg AR; Meritet JF; Fontanet A; Castan P; Madejón A; Laverick M; Glass A; Viana R; Pol S; McClure CP; Irving WL; Miele G; Albert ML; Duffy D
    Gut; 2018 Nov; 67(11):2017-2024. PubMed ID: 29615488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world utility of HCV core antigen as an alternative to HCV RNA testing: Implications for viral load and genotype.
    Pollock KG; McDonald SA; Gunson R; McLeod A; Went A; Goldberg DJ; Hutchinson SJ; Barclay ST
    J Viral Hepat; 2020 Oct; 27(10):996-1002. PubMed ID: 32479681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving Linkage to Care of Hepatitis C: Clinical Validation of GeneXpert® HCV Viral Load Point-of-Care Assay in Indonesia.
    Thedja MD; Wibowo DP; El-Khobar KE; Ie SI; Turyadi ; Setiawan L; Murti IS; Muljono DH
    Am J Trop Med Hyg; 2021 May; 105(1):117-124. PubMed ID: 33999849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular epidemiology and viral load of HCV in different regions of Punjab, Pakistan.
    Afridi SQ; Ali MM; Awan F; Zahid MN; Afridi IQ; Afridi SQ; Yaqub T
    Virol J; 2014 Feb; 11():24. PubMed ID: 24512668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotypes and viral load of hepatitis C virus among persons attending a voluntary counseling and testing center in Ethiopia.
    Abreha T; Woldeamanuel Y; Pietsch C; Maier M; Asrat D; Abebe A; Hailegiorgis B; Aseffa A; Liebert UG
    J Med Virol; 2011 May; 83(5):776-82. PubMed ID: 21351106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel diagnostic target in the hepatitis C virus genome.
    Drexler JF; Kupfer B; Petersen N; Grotto RM; Rodrigues SM; Grywna K; Panning M; Annan A; Silva GF; Douglas J; Koay ES; Smuts H; Netto EM; Simmonds P; Pardini MI; Roth WK; Drosten C
    PLoS Med; 2009 Feb; 6(2):e31. PubMed ID: 19209955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison setting.
    Sharafi H; Poustchi H; Azimian F; Tamadoni B; Ramezani R; Gouya MM; Sheikh M; Hashemi F; Tashakorian M; Alasvand R; Alavian SM; Merat S
    J Clin Virol; 2019 Apr; 113():20-23. PubMed ID: 30825832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Application of anti-HCV and HCV RNA detection in intravenous drug users].
    Xu B; Chen B; Ma ZH; Ren YN; Ma JQ; Pei LJ; Xing WW
    Zhonghua Gan Zang Bing Za Zhi; 2021 May; 29(5):415-420. PubMed ID: 34107577
    [No Abstract]   [Full Text] [Related]  

  • 16. Liver disease burden and required treatment expenditures for hepatitis C virus (HCV) infection in Thailand: Implications for HCV elimination in the new therapeutic era, a population-based study.
    Wasitthankasem R; Vichaiwattana P; Siripon N; Posuwan N; Auphimai C; Klinfueng S; Thanetkongtong N; Vuthitanachot V; Saiyatha S; Thongmai C; Sochoo S; Pongsuwan N; Poovorawan K; Tangkijvanich P; Poovorawan Y
    PLoS One; 2018; 13(4):e0196301. PubMed ID: 29689073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Xpert HCV Viral Load point-of-care assay from venepuncture-collected and finger-stick capillary whole-blood samples: a cohort study.
    Grebely J; Lamoury FMJ; Hajarizadeh B; Mowat Y; Marshall AD; Bajis S; Marks P; Amin J; Smith J; Edwards M; Gorton C; Ezard N; Persing D; Kleman M; Cunningham P; Catlett B; Dore GJ; Applegate TL;
    Lancet Gastroenterol Hepatol; 2017 Jul; 2(7):514-520. PubMed ID: 28442271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occult Hepatitis C Virus Infection among Hemodialysis Patients: An Iranian Experience.
    Taherpour S; Javanmard D; Ziaee M
    Arch Iran Med; 2020 Sep; 23(9):586-592. PubMed ID: 32979904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of an RT-qPCR assay for rapid detection and quantification of hepatitis C virus RNA for routine testing in Moroccan clinical specimens.
    El Hadi H; Benani A; Qmichou Z; Lazar F; Bakri Y; Ait Benhassou H; Moumen A
    J Med Virol; 2019 Mar; 91(3):428-436. PubMed ID: 30267578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Investigation of Anti-HCV S/CO Value in Detecting Viremia in Patients with Hepatitis C Virus Infection].
    Aydın G; Adaleti R; Boz ES; Yücel FM; Özhan HK; Aksaray S
    Mikrobiyol Bul; 2020 Jan; 54(1):110-119. PubMed ID: 32050882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.